Literature DB >> 20934553

Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapies.

Melissa H Kong1, Eric D Peterson, Gregg C Fonarow, Gillian D Sanders, Clyde W Yancy, Andrea M Russo, Anne B Curtis, Samuel F Sears, Kevin L Thomas, Susan Campbell, Mark D Carlson, Chris Chiames, Nakela L Cook, David L Hayes, Michelle LaRue, Adrian F Hernandez, Edward L Lyons, Sana M Al-Khatib.   

Abstract

Sudden cardiac arrest (SCA) is the most common cause of death in the Unites States. Despite its major impact on public health, significant challenges exist at the patient, provider, public, and policy levels with respect to raising more widespread awareness and understanding of SCA risks, identifying patients at risk for SCA, addressing barriers to SCA care, and eliminating disparities in SCA care and outcomes. To address many of these challenges, the Duke Center for the Prevention of Sudden Cardiac Death at the Duke Clinical Research Institute (Durham, NC) held a think tank meeting on December 7, 2009, convening experts on this issue from clinical cardiology, cardiac electrophysiology, health policy and economics, the US Food and Drug Administration, the Centers for Medicare and Medicaid Services, the Agency for Health Care Research and Quality, and device and pharmaceutical manufacturers. The specific goals of the meeting were to examine existing educational tools on SCA for patients, health care providers, and the public and explore ways to enhance and disseminate these tools; to propose a framework for improved identification of patients at risk of SCA; and to review the latest data on disparities in SCA care and explore ways to reduce these disparities. This article summarizes the discussions that occurred at the meeting.
Copyright © 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20934553      PMCID: PMC2956019          DOI: 10.1016/j.ahj.2010.07.011

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  51 in total

1.  Clinical expertise in the era of evidence-based medicine and patient choice.

Authors:  R Brian Haynes; P J Devereaux; Gordon H Guyatt
Journal:  ACP J Club       Date:  2002 Mar-Apr

2.  Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest.

Authors:  Peter W Groeneveld; Paul A Heidenreich; Alan M Garber
Journal:  Circulation       Date:  2003-06-30       Impact factor: 29.690

3.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

4.  Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000.

Authors:  Leonard A Cobb; Carol E Fahrenbruch; Michele Olsufka; Michael K Copass
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

5.  Sudden cardiac death in the United States, 1989 to 1998.

Authors:  Z J Zheng; J B Croft; W H Giles; G A Mensah
Journal:  Circulation       Date:  2001-10-30       Impact factor: 29.690

6.  Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors:  Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

7.  The effectiveness of local adaptation of nationally produced clinical practice guidelines.

Authors:  C A Silagy; D P Weller; H Lapsley; P Middleton; T Shelby-James; B Fazekas
Journal:  Fam Pract       Date:  2002-06       Impact factor: 2.267

8.  Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).

Authors:  Gregg C Fonarow; Nancy M Albert; Anne B Curtis; Wendy Gattis Stough; Mihai Gheorghiade; J Thomas Heywood; Mark L McBride; Patches Johnson Inge; Mandeep R Mehra; Christopher M O'Connor; Dwight Reynolds; Mary Norine Walsh; Clyde W Yancy
Journal:  Circulation       Date:  2010-07-26       Impact factor: 29.690

Review 9.  The role of in-hospital initiation of cardioprotective therapies to improve treatment rates and clinical outcomes.

Authors:  Gregg C Fonarow
Journal:  Rev Cardiovasc Med       Date:  2002       Impact factor: 2.930

10.  Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

Authors:  A Hjalmarson; S Goldstein; B Fagerberg; H Wedel; F Waagstein; J Kjekshus; J Wikstrand; D El Allaf; J Vítovec; J Aldershvile; M Halinen; R Dietz; K L Neuhaus; A Jánosi; G Thorgeirsson; P H Dunselman; L Gullestad; J Kuch; J Herlitz; P Rickenbacher; S Ball; S Gottlieb; P Deedwania
Journal:  JAMA       Date:  2000-03-08       Impact factor: 56.272

View more
  3 in total

1.  Communication Strategies Must Be Tailored to a Medication's Targeted Population: Lessons from the Case of BiDil.

Authors:  Chamika Hawkins-Taylor; Angeline M Carlson
Journal:  Am Health Drug Benefits       Date:  2013-09

2.  Do acute changes in ambient air pollution increase the risk of potentially fatal cardiac arrhythmias in patients with implantable cardioverter defibrillators?

Authors:  Robert Dales; Douglas S Lee; Xuesong Wang; Sabit Cakmak; Mieczyslaw Szyszkowicz; Robin Shutt; David Birnie
Journal:  Environ Health       Date:  2020-06-18       Impact factor: 5.984

3.  Association of Racial Bias With Burnout Among Resident Physicians.

Authors:  Liselotte Dyrbye; Jeph Herrin; Colin P West; Natalie M Wittlin; John F Dovidio; Rachel Hardeman; Sara Emily Burke; Sean Phelan; Ivuoma Ngozi Onyeador; Brooke Cunningham; Michelle van Ryn
Journal:  JAMA Netw Open       Date:  2019-07-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.